A recent clinical trial conducted at Queen’s University (Kingston, Ontario) has reported that low-dose nitroglycerin might slow or stop prostate cancer progression, without significant side e
A recent study has concluded that men undergoing surgical treatment for prostate cancer have a survival benefit if the radical prostatectomy is completed, regardless of their lymph node status.
A new class of synthetic molecules developed by scientists at Yale University (New Haven, Connecticut) enhance the ability of the body’s immune system to recognize prostate cancer cells, and
Researchers at the Jewish General Hospital (affiliated with McGill University) in Montreal (Québec) have uncovered a new link between two genetic pathways that curtail the growth of tumours.